Follow The Filings

NUVB position history

The shares of Nuvation Bio (NUVB) that DME Capital Management reported in each quarter’s 13F.

Equity, COM CL A

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q1: 34,995 shares, $127K, <0.01% of portfolio
  2. 2024 Q2: 34,995 shares, $102K, <0.01% of portfolio
  3. 2024 Q3: 34,995 shares, $80K, <0.01% of portfolio
  4. 2024 Q4: 34,995 shares, $93K, <0.01% of portfolio
  5. 2025 Q1: 34,995 shares, $62K, <0.01% of portfolio
  6. 2025 Q2: 34,995 shares, $68K, <0.01% of portfolio
  7. 2025 Q3: 34,995 shares, $129K, <0.01% of portfolio
  8. 2025 Q4: 34,995 shares, $314K, 0.01% of portfolio
  9. 2026 Q1: 34,995 shares, $150K, <0.01% of portfolio
  10. 2026 Q2: 34,995 shares, $199K, <0.01% of portfolio
  11. 2026 Q3: 34,995 shares, $196K, <0.01% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders